Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Wnt signaling in lung cancer.

Mazieres J, He B, You L, Xu Z, Jablons DM.

Cancer Lett. 2005 May 10;222(1):1-10. Review.

PMID:
15837535
2.

Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.

Urakami S, Shiina H, Enokida H, Kawakami T, Tokizane T, Ogishima T, Tanaka Y, Li LC, Ribeiro-Filho LA, Terashima M, Kikuno N, Adachi H, Yoneda T, Kishi H, Shigeno K, Konety BR, Igawa M, Dahiya R.

Clin Cancer Res. 2006 Jan 15;12(2):383-91.

3.

Deregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors.

Kim JT, Li J, Jang ER, Gulhati P, Rychahou PG, Napier DL, Wang C, Weiss HL, Lee EY, Anthony L, Townsend CM Jr, Liu C, Evers BM.

Carcinogenesis. 2013 May;34(5):953-61. doi: 10.1093/carcin/bgt018. Epub 2013 Jan 25.

4.

Wnt signaling: physiology and pathology.

Prunier C, Hocevar BA, Howe PH.

Growth Factors. 2004 Sep;22(3):141-50. Review.

PMID:
15518237
5.

WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors.

Pannone G, Bufo P, Santoro A, Franco R, Aquino G, Longo F, Botti G, Serpico R, Cafarelli B, Abbruzzese A, Caraglia M, Papagerakis S, Lo Muzio L.

Oncol Rep. 2010 Oct;24(4):1035-41.

PMID:
20811686
6.

Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines.

Lin YC, You L, Xu Z, He B, Mikami I, Thung E, Chou J, Kuchenbecker K, Kim J, Raz D, Yang CT, Chen JK, Jablons DM.

Biochem Biophys Res Commun. 2006 Mar 10;341(2):635-40. Epub 2006 Jan 17.

PMID:
16427602
7.

Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.

Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K, Adachi Y, Endo T, Imai K, Shinomura Y.

Oncogene. 2005 Nov 24;24(53):7946-52.

PMID:
16007117
8.

Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.

Aguilera O, Fraga MF, Ballestar E, Paz MF, Herranz M, Espada J, García JM, Muñoz A, Esteller M, González-Sancho JM.

Oncogene. 2006 Jul 6;25(29):4116-21. Epub 2006 Feb 20.

PMID:
16491118
9.

Wnt/beta-catenin signaling pathway as a novel cancer drug target.

Luu HH, Zhang R, Haydon RC, Rayburn E, Kang Q, Si W, Park JK, Wang H, Peng Y, Jiang W, He TC.

Curr Cancer Drug Targets. 2004 Dec;4(8):653-71. Review.

PMID:
15578921
10.

Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer.

Tan M, Wu J, Cai Y.

Biochem Biophys Res Commun. 2013 Sep 6;438(4):673-9. doi: 10.1016/j.bbrc.2013.07.123. Epub 2013 Aug 9.

PMID:
23939044
11.

Secreted antagonists of the Wnt signalling pathway.

Kawano Y, Kypta R.

J Cell Sci. 2003 Jul 1;116(Pt 13):2627-34. Review.

12.

Secreted WNT antagonists as tumor suppressors: pro and con.

Rubin JS, Barshishat-Kupper M, Feroze-Merzoug F, Xi ZF.

Front Biosci. 2006 Sep 1;11:2093-105. Review.

PMID:
16720296
13.

Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer.

Mazieres J, He B, You L, Xu Z, Lee AY, Mikami I, Reguart N, Rosell R, McCormick F, Jablons DM.

Cancer Res. 2004 Jul 15;64(14):4717-20.

14.

Wnt signaling in osteosarcoma.

Lin CH, Ji T, Chen CF, Hoang BH.

Adv Exp Med Biol. 2014;804:33-45. doi: 10.1007/978-3-319-04843-7_2. Review.

PMID:
24924167
15.

[Dual-role regulations of canonical Wnt/beta-catenin signaling pathway].

Liu Y, Zhang CG, Zhou CY.

Beijing Da Xue Xue Bao. 2010 Apr 18;42(2):238-42. Review. Chinese.

16.

The WIF domain of the human and Drosophila Wif-1 secreted factors confers specificity for Wnt or Hedgehog.

Sánchez-Hernández D, Sierra J, Ortigão-Farias JR, Guerrero I.

Development. 2012 Oct;139(20):3849-58. Epub 2012 Sep 5. Erratum in: Development. 2013 Nov;140(22):4645.

17.

Elevated expression of Wnt antagonists is a common event in hepatoblastomas.

Koch A, Waha A, Hartmann W, Hrychyk A, Schüller U, Waha A, Wharton KA Jr, Fuchs SY, von Schweinitz D, Pietsch T.

Clin Cancer Res. 2005 Jun 15;11(12):4295-304.

18.

Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance.

Doucas H, Garcea G, Neal CP, Manson MM, Berry DP.

Eur J Cancer. 2005 Feb;41(3):365-79. Review.

PMID:
15691635
19.

Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer.

Masuda M, Sawa M, Yamada T.

Pharmacol Ther. 2015 Dec;156:1-9. doi: 10.1016/j.pharmthera.2015.10.009. Epub 2015 Nov 2. Review.

20.

Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor.

Mitsui Y, Yasumoto H, Nagami T, Hiraki M, Arichi N, Ishikawa N, Araki A, Maruyama R, Tanaka Y, Dahiya R, Shiina H.

Oncotarget. 2014 Apr 30;5(8):2198-207.

Supplemental Content

Support Center